Scott Braunstein

Scott Braunstein

Chief Executive Officer presso MARINUS PHARMACEUTICALS, INC.

Patrimonio netto: 970 209 $ in data 31/03/2024

60 anni
Health Technology
Finance
Consumer Services

Profilo

Scott N.
Braunstein
is currently the Chairman, President & Chief Executive Officer at Marinus Pharmaceuticals, Inc. He is also an Independent Director at Caribou Biosciences, Inc., the Lead Independent Director at Trevena, Inc., a Director at SiteOne Therapeutics, Inc., and a Director at Cornell University College of Agriculture & Life Sciences, BWBC I LLC, and Bent Water Brewing Corp.
Additionally, he serves as an Operating Partner at Aisling Capital LLC.
In his former roles, Braunstein served as the Chairman of ArTara Subsidiary, Inc. He was also a Managing Director at JPMorgan Investment Management, Inc. from 2002 to 2014.
He served as an Independent Director at Esperion Therapeutics, Inc. from 2015 to 2020.
Braunstein was a Managing Director & Senior Portfolio Manager at JPMorgan Chase & Co. from 2002 to 2014.
He also served as a Director at Alaunos Therapeutics, Inc. from 2018 to 2020, Constellation Pharmaceuticals, Inc. from 2019 to 2021, and Protara Therapeutics, Inc. from 2018 to 2020.
Additionally, he was a Principal at Deutsche Bank AG from 2000 to 2002 and Vice President-Operations at Cello Health BioConsulting Inc. from 1999 to 2000.
Braunstein served as the Chief Operating Officer at Pacira Biosciences, Inc. from 2017 to 2018 and was a Portfolio Manager at EverPoint Asset Management LLC from 2014 to 2015.
He also worked as a Physician at Summit Medical Group LLC and was a Portfolio Manager at JPMorgan Global Healthcare Fund.
Braunstein received his undergraduate degree from Cornell University in 1986 and his doctorate degree from Albert Einstein College of Medicine, Inc. in 1990.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
01/04/2024 107 324 ( 0.20% ) 970 209 $ 31/03/2024
09/02/2024 0 ( -.--% ) - $ 31/03/2024
20/02/2024 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Scott Braunstein

SocietàPosizioneInizio
MARINUS PHARMACEUTICALS, INC. Chief Executive Officer 12/08/2019
TREVENA, INC. Director/Board Member 01/09/2018
CARIBOU BIOSCIENCES, INC. Director/Board Member 01/06/2021
Private Equity Investor 01/09/2015
Director/Board Member -
Director/Board Member -
Director/Board Member 11/09/2018
Chief Operating Officer 01/01/2010
Cornell University College of Agriculture & Life Sciences Director/Board Member -
Tutte le posizioni attive di Scott Braunstein

Precedenti posizioni note di Scott Braunstein

SocietàPosizioneFine
░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Scott Braunstein

Formazione di Scott Braunstein

Cornell University Undergraduate Degree
Albert Einstein College of Medicine, Inc. Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Scott Braunstein

Relazioni

100 +

Relazioni di 1° grado

25

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa9
DEUTSCHE BANK AG

Finance

ESPERION THERAPEUTICS, INC.

Health Technology

JPMORGAN CHASE & CO.

Finance

MARINUS PHARMACEUTICALS, INC.

Health Technology

CARIBOU BIOSCIENCES, INC.

Health Technology

PACIRA BIOSCIENCES, INC.

Health Technology

ALAUNOS THERAPEUTICS, INC.

Health Technology

TREVENA, INC.

Health Technology

PROTARA THERAPEUTICS, INC.

Health Technology

Aziende private12

Finance

Finance

Commercial Services

JPMorgan Global Healthcare Fund

Miscellaneous

Commercial Services

Health Technology

Finance

Health Technology

Health Services

Health Technology

Consumer Non-Durables

Consumer Non-Durables

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Scott Braunstein